Tianjin Tianyao Pharmaceuticals Co Ltd (600488) — Capital Reinvestment Ratio
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Capital Reinvestment Ratio of 1.33x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥13.19 Million) in capital expenditures (CN¥17.49 Million). See 600488 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tianjin Tianyao Pharmaceuticals Co Ltd Capital Reinvestment Ratio (2000–2024)
This chart tracks Tianjin Tianyao Pharmaceuticals Co Ltd's Capital Reinvestment Ratio across 23 annual periods. Check Tianjin Tianyao Pharmaceuticals Co Ltd (600488) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Year-by-year Capital Reinvestment Ratio for Tianjin Tianyao Pharmaceuticals Co Ltd from 2000 to 2024. For live market cap and broader valuation context, see Tianjin Tianyao Pharmaceuticals Co Ltd (600488) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | CN¥569.37 Million | CN¥77.74 Million | ▼ -19.7% |
| 2023 | 0.17x | CN¥783.01 Million | CN¥133.15 Million | ▼ -45.0% |
| 2022 | 0.31x | CN¥653.52 Million | CN¥202.20 Million | ▼ -73.6% |
| 2021 | 1.17x | CN¥316.89 Million | CN¥370.84 Million | ▼ -11.5% |
| 2020 | 1.32x | CN¥346.88 Million | CN¥458.51 Million | ▲ +32.3% |
| 2019 | 1.00x | CN¥279.37 Million | CN¥279.04 Million | ▼ -7.1% |
| 2018 | 1.08x | CN¥189.27 Million | CN¥203.58 Million | ▲ +5.1% |
| 2016 | 1.02x | CN¥63.32 Million | CN¥64.78 Million | ▲ +192.3% |
| 2015 | 0.35x | CN¥129.50 Million | CN¥45.32 Million | ▲ +272.9% |
| 2014 | 0.09x | CN¥178.76 Million | CN¥16.78 Million | ▼ -97.4% |
| 2013 | 3.67x | CN¥84.55 Million | CN¥310.08 Million | ▼ -35.8% |
| 2012 | 5.71x | CN¥13.23 Million | CN¥75.59 Million | ▲ +614.5% |
| 2011 | 0.80x | CN¥78.47 Million | CN¥62.76 Million | ▼ -36.8% |
| 2010 | 1.26x | CN¥116.82 Million | CN¥147.76 Million | ▲ +172.0% |
| 2009 | 0.46x | CN¥435.13 Million | CN¥202.32 Million | ▼ -71.5% |
| 2008 | 1.63x | CN¥219.31 Million | CN¥357.63 Million | ▲ +17.8% |
| 2007 | 1.38x | CN¥162.33 Million | CN¥224.74 Million | ▼ -1.0% |
| 2006 | 1.40x | CN¥50.72 Million | CN¥70.91 Million | ▲ +15.5% |
| 2004 | 1.21x | CN¥110.30 Million | CN¥133.47 Million | ▼ -68.2% |
| 2003 | 3.81x | CN¥45.77 Million | CN¥174.24 Million | ▲ +0.7% |
| 2002 | 3.78x | CN¥45.28 Million | CN¥171.20 Million | ▲ +459.5% |
| 2001 | 0.68x | CN¥71.87 Million | CN¥48.57 Million | ▼ -23.5% |
| 2000 | 0.88x | CN¥41.06 Million | CN¥36.29 Million | — |